YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

A Study of Intravaginal Misoprostol for Induction of Labor in Toxemia of Pregnancy

dc.authorscopusid 26027617800
dc.authorscopusid 35577753600
dc.authorscopusid 15821566300
dc.authorscopusid 15820663700
dc.authorwosid Şahin, Hüseyin Avni/Jwo-9166-2024
dc.contributor.author Sahin, HG
dc.contributor.author Sahin, HA
dc.contributor.author Surucu, R
dc.contributor.author Guvercinci, M
dc.date.accessioned 2025-05-10T17:15:28Z
dc.date.available 2025-05-10T17:15:28Z
dc.date.issued 2001
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Univ Yuzuncu Yil, Fac Med, Dept Obstet & Gynecol, Van, Turkey; Univ Yuzuncu Yil, Fac Med, Dept Family Med, Van, Turkey en_US
dc.description.abstract Objective: To compare the efficacy and complications of intravaginal misoprostol for induction of labor in patients with and without toxemia of pregnancy. Methods: Forty-two patients with toxemia of pregnancy (group 1) and 59 women at term without toxemia (group 2) with Bishop scores of less than or equal to 6 were treated with 50 mug intravaginal misoprostol given four times at 4-h intervals. Labor and neonatal outcomes, and any complications, were recorded. Mann-Whitney U-, Student's t- and chi (2)-tests were used for statistical analyses. P less than or equal to 0.05 was considered significant. Results: The rates of vaginal delivery were 73.8% and 84.6%, oxytocin augmentation were 4.8% and 5.1% and the mean insertion to delivery times were 12.5 and 13.8 h in group 1 and 2, respectively, with no significant differences between the groups. Neonatal outcomes, rates of uterine contraction abnormalities and gastrointestinal symptoms were similar in both groups. Conclusions: Intravaginal misoprostol is an equally effective and safe method of induction of labor in patients with toxemia of pregnancy and in normal pregnant women. (C) 2001 International Federation of Gynecology and Obstetrics. All rights reserved. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1016/S0020-7292(01)00449-0
dc.identifier.endpage 9 en_US
dc.identifier.issn 0020-7292
dc.identifier.issue 1 en_US
dc.identifier.pmid 11597613
dc.identifier.scopus 2-s2.0-0035707658
dc.identifier.scopusquality Q1
dc.identifier.startpage 3 en_US
dc.identifier.uri https://doi.org/10.1016/S0020-7292(01)00449-0
dc.identifier.uri https://hdl.handle.net/20.500.14720/8632
dc.identifier.volume 75 en_US
dc.identifier.wos WOS:000172549600001
dc.identifier.wosquality Q2
dc.language.iso en en_US
dc.publisher Elsevier Sci Ireland Ltd en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Misoprostol en_US
dc.subject Induction Of Labor en_US
dc.subject Toxemia Of Pregnancy en_US
dc.title A Study of Intravaginal Misoprostol for Induction of Labor in Toxemia of Pregnancy en_US
dc.type Article en_US

Files